Maitane Asensio

878 total citations
18 papers, 605 citations indexed

About

Maitane Asensio is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Maitane Asensio has authored 18 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Maitane Asensio's work include Drug Transport and Resistance Mechanisms (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Maitane Asensio is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Maitane Asensio collaborates with scholars based in Spain, Germany and Italy. Maitane Asensio's co-authors include José J.G. Marı́n, Óscar Briz, Rocı́o I.R. Macı́as, Elisa Lozano, Marta R. Romero, Elisa Herráez, Thomas Efferth, Candela Cives-Losada, Silvia Di Giacomo and María J. Monte and has published in prestigious journals such as Hepatology, Biochemical Pharmacology and American Journal of Physiology-Cell Physiology.

In The Last Decade

Maitane Asensio

17 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maitane Asensio Spain 13 294 253 163 127 90 18 605
Quanbao Zhang China 16 252 0.9× 164 0.6× 106 0.7× 135 1.1× 87 1.0× 40 603
Pingping Dong China 13 323 1.1× 231 0.9× 98 0.6× 146 1.1× 56 0.6× 39 740
Christopher D. Mann United Kingdom 12 290 1.0× 359 1.4× 230 1.4× 180 1.4× 107 1.2× 15 768
Daichi Ishikawa Japan 20 340 1.2× 289 1.1× 207 1.3× 189 1.5× 147 1.6× 48 851
Jianyong Zhuo China 14 280 1.0× 134 0.5× 120 0.7× 123 1.0× 157 1.7× 40 637
Shuling Huang China 16 444 1.5× 278 1.1× 193 1.2× 164 1.3× 64 0.7× 25 854
Miral S. Grandhi United States 8 198 0.7× 144 0.6× 117 0.7× 173 1.4× 163 1.8× 39 544
Rocky L.K. Ho Hong Kong 13 280 1.0× 212 0.8× 146 0.9× 152 1.2× 139 1.5× 16 677

Countries citing papers authored by Maitane Asensio

Since Specialization
Citations

This map shows the geographic impact of Maitane Asensio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maitane Asensio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maitane Asensio more than expected).

Fields of papers citing papers by Maitane Asensio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maitane Asensio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maitane Asensio. The network helps show where Maitane Asensio may publish in the future.

Co-authorship network of co-authors of Maitane Asensio

This figure shows the co-authorship network connecting the top 25 collaborators of Maitane Asensio. A scholar is included among the top collaborators of Maitane Asensio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maitane Asensio. Maitane Asensio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Asensio, Maitane, Óscar Briz, Elisa Herráez, et al.. (2024). Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3. Biomedicine & Pharmacotherapy. 180. 117533–117533.
2.
Marı́n, José J.G., Candela Cives-Losada, Rocı́o I.R. Macı́as, et al.. (2024). Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition. Biochemical Pharmacology. 228. 116166–116166. 2 indexed citations
3.
Marı́n, José J.G., Rocı́o I.R. Macı́as, Maitane Asensio, et al.. (2024). Strategies to enhance the response of liver cancer to pharmacological treatments. American Journal of Physiology-Cell Physiology. 327(1). C11–C33. 2 indexed citations
4.
Asensio, Maitane, Elisa Herráez, Rocı́o I.R. Macı́as, et al.. (2023). Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma. Biochemical Pharmacology. 214. 115681–115681. 10 indexed citations
5.
Marı́n, José J.G., María J. Monte, Rocı́o I.R. Macı́as, et al.. (2022). Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers. Cancers. 14(14). 3524–3524. 25 indexed citations
6.
Mascaraque, Cristina, et al.. (2022). Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models. Pharmacological Research. 177. 106056–106056. 32 indexed citations
7.
Asensio, Maitane, et al.. (2022). Etiopathogenesis and pathophysiology of cholestasis. 97–117. 3 indexed citations
8.
Marı́n, José J.G., Marta R. Romero, Elisa Herráez, et al.. (2021). Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems. Seminars in Liver Disease. 42(1). 87–103. 12 indexed citations
9.
Marı́n, José J.G., Elisa Lozano, Maitane Asensio, et al.. (2021). Impact of Alternative Splicing Variants on Liver Cancer Biology. Cancers. 14(1). 18–18. 17 indexed citations
10.
Lozano, Elisa, et al.. (2021). Impact of alternative splicing on mechanisms of resistance to anticancer drugs. Biochemical Pharmacology. 193. 114810–114810. 18 indexed citations
11.
Abdelfatah, Sara, Maitane Asensio, Onat Kadioglu, et al.. (2020). Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. Phytomedicine. 86. 153196–153196. 42 indexed citations
12.
Marı́n, José J.G., Rocı́o I.R. Macı́as, María J. Monte, et al.. (2020). Molecular Bases of Drug Resistance in Hepatocellular Carcinoma. Cancers. 12(6). 1663–1663. 128 indexed citations
13.
Marı́n, José J.G., Rocı́o I.R. Macı́as, Maitane Asensio, et al.. (2020). Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma. Cancers. 12(8). 2116–2116. 44 indexed citations
14.
Lozano, Elisa, et al.. (2019). MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression. Hepatology. 72(3). 949–964. 22 indexed citations
15.
Lozano, Elisa, Rocı́o I.R. Macı́as, María J. Monte, et al.. (2019). Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy. Hepatology. 70(4). 1246–1261. 41 indexed citations
16.
Marı́n, José J.G., Candela Cives-Losada, Maitane Asensio, et al.. (2019). Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers. 11(3). 407–407. 41 indexed citations
17.
Marı́n, José J.G., Óscar Briz, Elisa Herráez, et al.. (2018). Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology. 42(3). 182–192. 68 indexed citations
18.
Marı́n, José J.G., Elisa Lozano, Elisa Herráez, et al.. (2017). Chemoresistance and chemosensitization in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1444–1453. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026